USFDA Approves LaNeo MDMA for Clinical Trial Use in the
Approved Study to Examine Tolerability of MDMA in Schizophrenia at UCLA VANCOUVER, British Columbia, June 09, 2023 (GLOBE NEWSWIRE) -- PharmAla Biotech...
Source: globenewswire.com
📰 Approved Study News
Approved Study News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Approved Study. Real-time updates on events, politics, business and more.
USFDA Approves LaNeo MDMA for Clinical Trial Use in the United States
Approved Study to Examine Tolerability of MDMA in Schizophrenia at UCLA VANCOUVER, British Columbia, June 09, 2023 -- PharmAla Biotech Holdings Inc. , a biotechnology company focused on the... | June 10, 2023
Source: marketscreener.com